ARTICLES
J&J’s Insider Sell Is a Warning, But the Pharma Moat Is Quietly Compounding
When a top executive at Johnson & Johnson sells nearly half her stake — $5.8 million worth of shares — ...
Read More
Read More
The Hidden Bet Against AI Hardware: Healthcare and Banks Quietly Undervalued
While semiconductor stocks were grabbing headlines with a jaw-dropping 111% surge between late March and late June of 2026, a ...
Read More
Read More
UPS and FedEx Are Quietly Compounding a $39 Billion Healthcare Logistics Moat
While Wall Street obsesses over AI chips and hyperscaler capex, two of America's most recognizable logistics companies are quietly building ...
Read More
Read More
Ackman’s 2,644% Compounder Goes Public — But Long-Term Investors Should Look Past the IPO Flop
When Bill Ackman's Pershing Square USA (PSUS) debuted on the New York Stock Exchange in late April, it dropped 18% ...
Read More
Read More
Mastercard’s Unbreakable Payments Moat Is Quietly Undervalued Right Now
While investors pour money into semiconductors and AI data centers, Mastercard sits quietly in the background — processing the financial ...
Read More
Read More
